[1]黄文坚,柯智元.慢性阻塞性肺疾病急性加重期患者体成分的临床评价[J].医学信息,2024,37(16):41-46.[doi:10.3969/j.issn.1006-1959.2024.16.008]
　HUANG Wen-jian,KE Zhi-yuan.Clinical Evaluation of Body Composition in Patients with Acute Exacerbationof Chronic Obstructive Pulmonary Disease[J].Journal of Medical Information,2024,37(16):41-46.[doi:10.3969/j.issn.1006-1959.2024.16.008]
点击复制

慢性阻塞性肺疾病急性加重期患者体成分的临床评价()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
37卷
期数:
2024年16期
页码:
41-46
栏目:
论著
出版日期:
2024-08-15

文章信息/Info

Title:
Clinical Evaluation of Body Composition in Patients with Acute Exacerbationof Chronic Obstructive Pulmonary Disease
文章编号:
1006-1959（2024）16-0041-06
作者:
黄文坚1; 2; 柯智元1; 2; 3
1.福建医科大学公共卫生学院，福建 福州 350100；2.福建医科大学附属第二医院临床营养科，福建 泉州 362000；3.福建医科大学医学技术与工程学院，福建 福州 350100
Author(s):
HUANG Wen-jian1; 2; KE Zhi-yuan1; 2; 3
1.School of Public Health,Fujian Medical University,Fuzhou 350100,Fujian,China; 2.Department of Clinical Nutrition,the Second Affiliated Hospital of Fujian Medical University,Quanzhou 362000,Fujian,China; 3.School of Medical Technology and Engineering,Fujian Medical University,Fuzhou 350100,Fujian,China
关键词:
慢性阻塞性肺病; 体成分; 恶化风险; myomiRs; 营养
Keywords:
Chronic obstructive pulmonary disease; Body composition; Deterioration risk; myomiRs; Nutrition
分类号:
R563
DOI:
10.3969/j.issn.1006-1959.2024.16.008
文献标志码:
A
摘要:
目的 分析慢性阻塞性肺疾病急性加重期（AECOPD）患者的体成分与疾病恶化风险和肌源性microRNA（myomiRs）表达水平的相关性。方法 选取2021年2月-2022年12月在福建医科大学附属第二医院就诊的77例AECOPD患者的基本资料和血液样本，采用人体成分分析仪测量体成分，运用逆转录-聚合酶链式反应技术检测血浆中myomiRs含量。将每年加重2次或2次以上的患者列入高恶化风险组（55例），少于2次的列入低恶化风险组（22例）。比较两组体成分差异，探索其与疾病恶化和血浆myomiRs水平的关系。结果 高恶化风险组去脂体重、去脂体重指数与相位角低于低恶化风险组，细胞外水分比率高于低恶化风险组，差异有统计学意义（P＜0.05）；高恶化风险组的细胞内液与身体总水分低于低恶化风险组（P＜0.05）；逻辑回归分析显示，细胞外水分比率（OR=1.086，95%CI：1.010~1.168，P=0.026）和相位角（OR=0.396，95%CI：0.164~0.957，P=0.040）与疾病恶化风险独立相关。依据受试者工作特征曲线，鉴别恶化风险时，细胞外水分比率与相位角的阈值分别是0.393%和4.85°；AECOPD患者的脂肪参数（脂肪量、脂肪指数、体脂百分比和内脏脂肪面积）与miR-206表达水平呈负相关。结论 细胞外水分比率和相位角可用于鉴别AECOPD患者恶化风险。此外，miR-206与AECOPD患者的脂肪参数相关，表明脂肪可能参与患者肌肉衰减症的调控过程。
Abstract:
Objective To analyze the correlation between body composition and the risk of disease progression and the expression level of myogenic microRNAs (myomiRs) in patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD).Methods The basic data and blood samples of 77 patients with AECOPD who were treated in the Second Affiliated Hospital of Fujian Medical University from February 2021 to December 2022 were selected. The body composition was measured by the body composition analyzer, and the content of myomiRs in plasma was detected by reverse transcription-polymerase chain reaction. Patients with two or more exacerbations per year were included in the high deterioration risk group (55 patients) and those with less than two exacerbations were included in the low deterioration risk group (22 patients). The differences in body composition between the two groups were compared to explore its relationship with disease progression and plasma myomiRs levels.Results The fat-free weight, fat-free body mass index and phase angle of the high deterioration risk group were lower than those of the low deterioration risk group, and the extracellular water ratio was higher than that of the low deterioration risk group, the difference were statistically significant (P<0.05). The intracellular fluid and total body water in the high deterioration risk group were lower than those in the low deterioration risk group (P<0.05). Logistic regression analysis showed that extracellular water ratio (OR=1.086, 95%CI: 1.010-1.168, P=0.026 ) and phase angle (OR=0.396, 95%CI: 0.164-0.957, P=0.040) were independently associated with the risk of disease progression. According to the receiver operating characteristic curve, the thresholds of extracellular water ratio and phase angle were 0.393% and 4.85°, respectively. The fat parameters (fat mass, fat index, body fat percentage and visceral fat area) of AECOPD patients were negatively correlated with the expression level of miR-206.Conclusion The extracellular water ratio and phase angle can be used to identify the deterioration risk of AECOPD patients. In addition, miR-206 is associated with fat parameters in patients with AECOPD, indicating that fat may be involved in the regulation of sarcopenia in patients.

参考文献/References:

[1]Asia Pacific COPD Roundtable Group.Global Initiative for Chronic Obstructive Lung Disease strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease:an Asia-Pacific perspective[J].Respirology,2005,10(1):9-17.[2]侯珊珊,施劲东,尹欣,等.1990-2019年中国慢性阻塞性肺疾病的疾病负担情况分析[J].中华流行病学杂志,2022,43(10):1554-1561. [3]Collins PF,Yang IA,Chang YC,et al.Nutritional support in chronic obstructive pulmonary disease (COPD): an evidence update[J].J Thorac Dis,2019,11(Suppl17):S2230-S2237.[4]张学云,郑松柏.老年消化系统疾病与衰弱[J].中国临床保健杂志,2023,26(1):13-16.[5]Deng M,Lu Y,Zhang Q,et al.Global prevalence of malnutrition in patients with chronic obstructive pulmonary disease: Systemic review and meta-analysis[J].Clinical Nutrition,2023,42(6):848-858.[6]Ting HYT,Chan S,Luk E,et al.Prevalence of malnutrition in COPD inpatients and its relationship with nutritional intakes and clinical outcomes[J].Journal of Aging Science,2020,8:1000219.[7]赵云静,杨晓蕾,尹粉英,等.慢性阻塞性肺疾病合并肌少症的发病机制[J].中国老年保健医学,2023,21(1):110-113.[8]李宏月,温有锋,廉洁,等.慢性阻塞性肺疾病严重程度与骨骼肌营养不良的相关性研究[J].中国全科医学,2020,23(16):2044-2050.[9]Shen Y,Wang L,Wu Y,et al.A novel diagnostic signature based on three circulating exosomal mircoRNAs for chronic obstructive pulmonary disease[J].Exp Ther Med,2021,22(1):717.[10]Rothnie KJ,Mullerova H,Smeeth L,et al.Natural History of Chronic Obstructive Pulmonary Disease Exacerbations in a General Practice-based Population with Chronic Obstructive Pulmonary Disease[J].American Journal of Respiratory and Critical Care Medicine,2018,198(4):464-471.[11]Haughney J,Lee AJ,Nath M,et al.The long-term clinical impact of COPD exacerbations: a 3-year observational study (SHERLOCK)[J].Therapeutic Advances in Respiratory Disease,2022,16:17534666211070139.[12]Gattermann Pereira T,Lima J,Silva FM.Undernutrition is associated with mortality, exacerbation, and poorer quality of life in patients with chronic obstructive pulmonary disease: A systematic review with meta-analysis of observational studies[J].Journal of Parenteral and Enteral Nutrition,2022,46(5):977-996.[13]Karanikas I,Karayiannis D,Karachaliou A,et al.Body composition parameters and functional status test in predicting future acute exacerbation risk among hospitalized patients with chronic obstructive pulmonary disease[J].Clinical Nutrition,2021,40(11):5605-5614.[14]Yang L,Zhu Y,Huang JA,et al.A Low Lean-to-Fat Ratio Reduces the Risk of Acute Exacerbation of Chronic Obstructive Pulmonary Disease in Patients with a Normal or Low Body Mass Index[J].Medical Science Monitor,2019,25:5229-5236.[15]T?覬ttenborg SS,Thomsen RW,Johnsen SP,et al.Determinants of Smoking Cessation in Patients With COPD Treated in the Outpatient Setting[J].Chest,2016,150:554-562.[16]孙璐瑶.慢性阻塞性肺疾病脂质代谢异常的临床探讨[D].长春:吉林大学,2013.[17]Player EL,Morris P,Thomas T,et al.Bioelectrical impedance analysis (BIA)-derived phase angle (PA) is a practical aid to nutritional assessment in hospital in-patients[J].Clinical Nutrition,2019,38:1700-1706.[18]Gredic M,Blanco I,Kovacs G,et al.Pulmonary hypertension in chronic obstructive pulmonary disease[J].British Journal of Pharmacology,2021,178(1):132-151.[19]魏汉林.肺源性心脏病[M].北京:中国医药科技出版社,2010.[20]Pérez-Morales R,Donate-Correa J,Martín-Nú?觡ez E,et al.Extracellular water/total body water ratio as predictor of mortality in hemodialysis patients[J].Renal Failure,2021,43(1):821-829.[21]Wang X,Liang Q,Li Z,et al.Body Composition and COPD: A New Perspective[J].International Journal of Chronic Obstructive Pulmonary Disease,2023,18:79-97. [22]Uemura K,Doi T,Tsutsumimoto K,et al.Predictivity of bioimpedance phase angle for incident disability in older adults[J].Journal of Cachexia,Sarcopenia and Muscle,2020,11(1):46-54.[23]Di Vincenzo O,Marra M,Di Gregorio A,et al.Bioelectrical impedance analysis (BIA) -derived phase angle in sarcopenia: A systematic review[J].Clinical Nutrion,2021,40(5):3052-3061.[24]Zhao H,Li P,Wang J.The role of muscle-specific MicroRNAs in patients with chronic obstructive pulmonary disease and skeletal muscle dysfunction[J].Frontiers in Physiology,2022,13:954364.[25]Barreiro E,Sancho-Mu?觡oz A,Puig-Vilanova E,et al.Differences in micro-RNA expression profile between vastus lateralis samples and myotubes in COPD cachexia[J].J Appl Physiol (1985),2019,126(2):403-412.[26]Yin X,Cui S,Li X,et al.Regulation of Circulatory Muscle-specific MicroRNA during 8 km Run [J].International Journal of Sports Medicine,2020,41(9):582-588.[27]Wang A,Chen B,Jian S,et al.miR-206-G6PD axis regulates lipogenesis and cell growth in hepatocellular carcinoma cell[J].Anticancer Drugs,2021,32(5):508-516.

相似文献/References:

[1]李暾,徐伟,李强.ICU 病房应用无创呼吸机治疗老年COPD 并域型呼吸衰竭的临床疗效研究[J].医学信息,2018,31(01):106.[doi:10.3969/j.issn.1006-1959.2018.01.039]
　LI Tun,XU Wei,LI Qiang.Clinical Study of Noninvasive Ventilator in Elderly Patients with COPD and Type 域 Respiratory Failure in ICU Ward[J].Journal of Medical Information,2018,31(16):106.[doi:10.3969/j.issn.1006-1959.2018.01.039]
[2]郑 莹.COPD急诊发作常见的诱发因素进展研究[J].医学信息,2018,31(10):54.[doi:10.3969/j.issn.1006-1959.2018.10.017]
　ZHENG Ying.Research on the Common Inducing Factors of Emergency Attack in COPD[J].Journal of Medical Information,2018,31(16):54.[doi:10.3969/j.issn.1006-1959.2018.10.017]
[3]孟琳非,黄伟健,酆孟洁,等.基于聚类分析对慢性肺部疾病表型的研究进展[J].医学信息,2019,32(07):44.[doi:10.3969/j.issn.1006-1959.2019.07.015]
　MENG Lin-fei,HUANG Wei-jian,FENG Meng-jie,et al.Advances in Research on Phenotypes of Chronic Lung Diseases Based on Cluster Analysis[J].Journal of Medical Information,2019,32(16):44.[doi:10.3969/j.issn.1006-1959.2019.07.015]
[4]魏凯凡,赵 禹,李 秀.家庭无创通气对慢性阻塞性肺疾病合并Ⅱ型呼吸衰竭疗效的Meta分析[J].医学信息,2020,33(12):70.[doi:10.3969/j.issn.1006-1959.2020.12.021]
　WEI Kai-fan,ZHAO Yu,LI Xiu.Meta-analysis of the Effect of Family Noninvasive Ventilation on Chronic Obstructive Pulmonary Disease with Type Ⅱ Respiratory Failure[J].Journal of Medical Information,2020,33(16):70.[doi:10.3969/j.issn.1006-1959.2020.12.021]
[5]王岳宸.盐酸氨溴索联合N-乙酰半胱氨酸治疗老年COPD的效果及对患者血清VAP-1、SFRP-1、ECP水平的影响[J].医学信息,2021,34(10):110.[doi:10.3969/j.issn.1006-1959.2021.10.030]
　WANG Yue-chen.The Effect of Ambroxol Hydrochloride Combined with N-acetylcysteine in the Treatment of COPD in the Elderly and Its Effect on Patients’ Serum VAP-1,SFRP-1 and ECP Levels[J].Journal of Medical Information,2021,34(16):110.[doi:10.3969/j.issn.1006-1959.2021.10.030]
[6]远 颖.督灸改善慢性阻塞性肺病临床疗效及生存质量的Meta分析[J].医学信息,2022,35(01):93.[doi:10.3969/j.issn.1006-1959.2022.01.022]
　YUAN Ying.Meta-analysis of Governor Moxibustion to Improve Clinical Efficacy and Quality of Life of Chronic Obstructive Pulmonary Disease[J].Journal of Medical Information,2022,35(16):93.[doi:10.3969/j.issn.1006-1959.2022.01.022]
[7]吴嘉丽,胡 阳,李英华,等.超声评估膈肌功能的方法及其在临床中的应用[J].医学信息,2023,36(16):174.[doi:10.3969/j.issn.1006-1959.2023.16.036]
　WU Jia-li,HU Yang,LI Ying-hua,et al.The Method of Ultrasonic Evaluation of Diaphragmatic Function and its Clinical Application[J].Journal of Medical Information,2023,36(16):174.[doi:10.3969/j.issn.1006-1959.2023.16.036]
[8]殷 祎,苏 佳,王耘秋.肺康复训练联合营养干预治疗慢性阻塞性肺病合并肌少症患者的临床疗效及对生活质量的影响[J].医学信息,2024,37(09):122.[doi:10.3969/j.issn.1006-1959.2024.09.023]
　YIN Yi,SU Jia,WANG Yun-qiu.Clinical Efficacy of Pulmonary Rehabilitation Training Combined with Nutritional Intervention in the Treatment of Patients with Chronic Obstructive Pulmonary Disease Complicated with Sarcopenia and its Effect on Quality of Life[J].Journal of Medical Information,2024,37(16):122.[doi:10.3969/j.issn.1006-1959.2024.09.023]
[9]甘建国,肖春雨,甘山花,等.β2受体激动剂联合抗生素在慢性阻塞性肺病急性发作期的临床效果及安全性分析[J].医学信息,2024,37(23):109.[doi:10.3969/j.issn.1006-1959.2024.23.026]
　GAN Jianguo,XIAO Chunyu,GAN Shanhua,et al.Clinical Effect and Safety Analysis of β2 Receptor Agonist Combined with Antibiotics in Acute Exacerbation of Chronic Obstructive Pulmonary Disease[J].Journal of Medical Information,2024,37(16):109.[doi:10.3969/j.issn.1006-1959.2024.23.026]
[10]杨雅琳,胡 阳,魏云鸿,等.心率恢复在非心血管疾病中的应用价值及进展[J].医学信息,2025,38(01):185.[doi:10.3969/j.issn.1006-1959.2025.01.038]
　YANG Yalin,HU Yang,WEI Yunhong,et al.Application Value and Progress of Heart Rate Recovery in Non-cardiovascular Diseases[J].Journal of Medical Information,2025,38(16):185.[doi:10.3969/j.issn.1006-1959.2025.01.038]

更新日期/Last Update: 1900-01-01